Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Escherichia coli Vaccines"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 104
Tytuł:
A systematic review and meta-analysis on the efficacy of vaccination against colibacillosis in broiler production.
Autorzy:
Paudel S; Department of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong SAR.; Clinic for Poultry and Fish Medicine, Department for Farm Animals and Veterinary Public Health, University of Veterinary Medicine Vienna, Vienna, Austria.
Apostolakos I; Veterinary Research Institute, Hellenic Agricultural Organization 'DIMITRA', Thessaloniki, Greece.
Vougat Ngom R; Department of Animal Production, School of Veterinary Medicine and Sciences, University of Ngaoundere, Ngaoundéré, Cameroon.; Veterinary Public Health Institute, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Tilli G; Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, Italy.
de Carvalho Ferreira HC; Flanders Research Institute for Agriculture, Fisheries and Food, Merelbeke, Belgium.
Piccirillo A; Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, Italy.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 22; Vol. 19 (3), pp. e0301029. Date of Electronic Publication: 2024 Mar 22 (Print Publication: 2024).
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Poultry Diseases*/prevention & control
Escherichia coli Infections*/prevention & control
Escherichia coli Infections*/veterinary
Escherichia coli Vaccines*
Animals ; Escherichia coli ; Chickens ; Vaccination/veterinary
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development of a duplex qPCR for the differentiation of a live attenuated Escherichia coli aroA mutant vaccine strain from field isolates in chickens.
Autorzy:
Leurs K; Department of Pathobiology, Livestock Gut Health Team (LiGHT) Ghent, Pharmacology and Zoological Medicine, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Goossens E; Department of Pathobiology, Livestock Gut Health Team (LiGHT) Ghent, Pharmacology and Zoological Medicine, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Christensen H; Department of Veterinary Microbiology, Royal Veterinary and Agricultural University, Frederiksberg C, Denmark.
Mainil JG; Bacteriology Department of Infectious Diseases, Faculty of Veterinary Medicine, Centre for Fundamental and Applied Research in Animals and Health (FARAH), University of Liège (ULiège), Liège, Belgium.
Vancraeynest D; Zoetis, Parsippany, New Jersey, United States of America.
Ducatelle R; Department of Pathobiology, Livestock Gut Health Team (LiGHT) Ghent, Pharmacology and Zoological Medicine, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Van Immerseel F; Department of Pathobiology, Livestock Gut Health Team (LiGHT) Ghent, Pharmacology and Zoological Medicine, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Dec 19; Vol. 17 (12), pp. e0278949. Date of Electronic Publication: 2022 Dec 19 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Escherichia coli Vaccines*
Escherichia coli Infections*/veterinary
Poultry Diseases*/prevention & control
Animals ; Escherichia coli/genetics ; Chickens ; Vaccines, Attenuated
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy of passive immunization in broiler chicks via an inactivated Escherichia coli autogenous vaccine administered to broiler breeder hens.
Autorzy:
Keita A; Ploufragan-Plouzané-Niort Laboratory, Zoopôle les Croix Ploufragan, France.
Le Devendec L; Ploufragan-Plouzané-Niort Laboratory, Zoopôle les Croix Ploufragan, France.
Amelot M; Ploufragan-Plouzané-Niort Laboratory, Zoopôle les Croix Ploufragan, France.
Puterflam J; ITAVI Ploufragan, France.
Lucas C; Ploufragan-Plouzané-Niort Laboratory, Zoopôle les Croix Ploufragan, France.
Bougeard S; Ploufragan-Plouzané-Niort Laboratory, Zoopôle les Croix Ploufragan, France.
Delannoy S; ANSES - French Agency for Food, Environmental and Occupational Health and Safety Food Research Laboratory, Platform IdentyPath Maisons-Alfort, France.
Schouler C; INRAE, Université de Tours, Nouzilly, France.
Fach P; ANSES - French Agency for Food, Environmental and Occupational Health and Safety Food Research Laboratory, Platform IdentyPath Maisons-Alfort, France.
Lucas P; Ploufragan-Plouzané-Niort Laboratory, Zoopôle les Croix Ploufragan, France.
Souillard R; Ploufragan-Plouzané-Niort Laboratory, Zoopôle les Croix Ploufragan, France.
Kempf I; Ploufragan-Plouzané-Niort Laboratory, Zoopôle les Croix Ploufragan, France.
Pokaż więcej
Źródło:
Avian pathology : journal of the W.V.P.A [Avian Pathol] 2022 Oct; Vol. 51 (5), pp. 445-456. Date of Electronic Publication: 2022 Aug 05.
Typ publikacji:
Journal Article
MeSH Terms:
Autovaccines*
Escherichia coli Infections*/prevention & control
Escherichia coli Infections*/veterinary
Escherichia coli Vaccines*
Poultry Diseases*/microbiology
Animals ; Chickens/microbiology ; Escherichia coli ; Female ; Immunization, Passive/veterinary ; Ovum
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A multi-epitope fusion antigen candidate vaccine for Enterotoxigenic Escherichia coli is protective against strain B7A colonization in a rabbit model.
Autorzy:
Jones RM Jr; Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, Maryland, United States of America.; University of Washington, Department of Microbiology, Seattle, Washington, United States of America.
Seo H; University of Illinois at Urbana-Champaign, Department of Pathobiology, Urbana, Illinois, United States of America.
Zhang W; University of Illinois at Urbana-Champaign, Department of Pathobiology, Urbana, Illinois, United States of America.
Sack DA; Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, Maryland, United States of America.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2022 Feb 09; Vol. 16 (2), pp. e0010177. Date of Electronic Publication: 2022 Feb 09 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Antigens, Bacterial/*administration & dosage
Diarrhea/*prevention & control
Enterotoxigenic Escherichia coli/*growth & development
Enterotoxigenic Escherichia coli/*immunology
Epitopes/*immunology
Escherichia coli Infections/*prevention & control
Escherichia coli Vaccines/*administration & dosage
Animals ; Antibodies, Bacterial/blood ; Antigens, Bacterial/genetics ; Antigens, Bacterial/immunology ; Diarrhea/blood ; Diarrhea/microbiology ; Disease Models, Animal ; Enterotoxigenic Escherichia coli/genetics ; Epitopes/genetics ; Escherichia coli Infections/blood ; Escherichia coli Infections/microbiology ; Escherichia coli Vaccines/genetics ; Escherichia coli Vaccines/immunology ; Humans ; Immunization ; Intestine, Small/immunology ; Intestine, Small/microbiology ; Rabbits
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Combining pangenome analysis to identify potential cross-protective antigens against avian pathogenic Escherichia coli .
Autorzy:
Wang Z; College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, People's Republic of China.; Key Lab of Animal Bacteriology, Ministry of Agriculture, Nanjing, People's Republic of China.; OIE Reference Lab for Swine Streptococcosis, Nanjing, Jiangsu, People's Republic of China.
Zheng X; College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, People's Republic of China.; Key Lab of Animal Bacteriology, Ministry of Agriculture, Nanjing, People's Republic of China.; OIE Reference Lab for Swine Streptococcosis, Nanjing, Jiangsu, People's Republic of China.
Guo G; College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, People's Republic of China.; Key Lab of Animal Bacteriology, Ministry of Agriculture, Nanjing, People's Republic of China.; OIE Reference Lab for Swine Streptococcosis, Nanjing, Jiangsu, People's Republic of China.
Dong Y; Lab of Animal Disease Prevention and Control Center of Jiangsu Province, Nanjing, Jiangsu, People's Republic of China.
Xu Z; Lab of Animal Disease Prevention and Control Center of Jiangsu Province, Nanjing, Jiangsu, People's Republic of China.
Wei X; Guangxi Center for Animal Disease Control and Prevention, Nanning, Guangxi, People's Republic of China.
Han X; Shanghai Veterinary Research Institute, The Chinese Academy of Agricultural Sciences (CAAS), Shanghai, People's Republic of China.
Liu Y; Institute of Animal Science and Veterinary Medicine, Shandong Academy of Agricultural Sciences, Jinan, Shandong, People's Republic of China.
Zhang W; College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, People's Republic of China.; Key Lab of Animal Bacteriology, Ministry of Agriculture, Nanjing, People's Republic of China.; OIE Reference Lab for Swine Streptococcosis, Nanjing, Jiangsu, People's Republic of China.
Pokaż więcej
Źródło:
Avian pathology : journal of the W.V.P.A [Avian Pathol] 2022 Feb; Vol. 51 (1), pp. 66-75. Date of Electronic Publication: 2022 Jan 31.
Typ publikacji:
Journal Article
MeSH Terms:
Escherichia coli Infections*/prevention & control
Escherichia coli Infections*/veterinary
Escherichia coli Vaccines*
Poultry Diseases*/prevention & control
Animals ; Chickens ; Escherichia coli/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Designing and determining immunogenicity of a recombinant protein due to producing a new vaccine against Enterotoxigenic Escherichia coli containing CfaE and CotD subunits.
Autorzy:
Roghanian P; Department of Genetics, Islamic Azad University, Science and Research Branch, Tehran, Iran.
Zare Karizi S; Department of Genetics and Biotechnology, School of Biological Science, Varamin-Pishva, Branch Islamic Azad University, Varamin, Iran.
Motamedi MJ; Molecular Biology Department, Green Gene Company, Tehran, Iran.
Kazemi R; Molecular Biology Department, Green Gene Company, Tehran, Iran.
Khoobbakht D; Department of Genetics, Islamic Azad University, Science and Research Branch, Tehran, Iran.
Amani J; Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
Journal of immunoassay & immunochemistry [J Immunoassay Immunochem] 2021 Sep 03; Vol. 42 (5), pp. 525-542. Date of Electronic Publication: 2021 Apr 09.
Typ publikacji:
Journal Article
MeSH Terms:
Bacterial Toxins*
Enterotoxigenic Escherichia coli*/immunology
Escherichia coli Infections*/prevention & control
Escherichia coli Proteins*/genetics
Escherichia coli Vaccines*
Animals ; Antibodies, Bacterial ; Mice ; Mice, Inbred BALB C ; Recombinant Fusion Proteins/genetics ; Recombinant Proteins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design.
Autorzy:
Amcheslavsky A; MassBiologics, University of Massachusetts Medical School, 460 Walk Hill Road, Boston, MA, USA.
Wallace AL; MassBiologics, University of Massachusetts Medical School, 460 Walk Hill Road, Boston, MA, USA.
Ejemel M; MassBiologics, University of Massachusetts Medical School, 460 Walk Hill Road, Boston, MA, USA.
Li Q; MassBiologics, University of Massachusetts Medical School, 460 Walk Hill Road, Boston, MA, USA.
McMahon CT; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Stoppato M; MassBiologics, University of Massachusetts Medical School, 460 Walk Hill Road, Boston, MA, USA.
Giuntini S; MassBiologics, University of Massachusetts Medical School, 460 Walk Hill Road, Boston, MA, USA.
Schiller ZA; MassBiologics, University of Massachusetts Medical School, 460 Walk Hill Road, Boston, MA, USA.
Pondish JR; MassBiologics, University of Massachusetts Medical School, 460 Walk Hill Road, Boston, MA, USA.
Toomey JR; MassBiologics, University of Massachusetts Medical School, 460 Walk Hill Road, Boston, MA, USA.
Schneider RM; MassBiologics, University of Massachusetts Medical School, 460 Walk Hill Road, Boston, MA, USA.
Meisinger J; MassBiologics, University of Massachusetts Medical School, 460 Walk Hill Road, Boston, MA, USA.
Heukers R; QVQ Holdings BV, Utrecht, The Netherlands.
Kruse AC; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Barry EM; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA.
Pierce BG; University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, MD, USA.
Klempner MS; MassBiologics, University of Massachusetts Medical School, 460 Walk Hill Road, Boston, MA, USA.
Cavacini LA; MassBiologics, University of Massachusetts Medical School, 460 Walk Hill Road, Boston, MA, USA.
Wang Y; MassBiologics, University of Massachusetts Medical School, 460 Walk Hill Road, Boston, MA, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Feb 02; Vol. 11 (1), pp. 2751. Date of Electronic Publication: 2021 Feb 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diarrhea/*prevention & control
Enterotoxigenic Escherichia coli/*immunology
Escherichia coli Infections/*prevention & control
Escherichia coli Vaccines/*administration & dosage
Single-Domain Antibodies/*administration & dosage
Animals ; Antibodies, Bacterial/administration & dosage ; Antibodies, Bacterial/immunology ; Antibodies, Neutralizing/administration & dosage ; Antibodies, Neutralizing/immunology ; Caco-2 Cells ; Camelids, New World ; Cross Protection ; Diarrhea/immunology ; Diarrhea/microbiology ; Disease Models, Animal ; Drug Design ; Epitope Mapping ; Epitopes/immunology ; Escherichia coli Infections/immunology ; Escherichia coli Proteins/antagonists & inhibitors ; Escherichia coli Proteins/immunology ; Escherichia coli Vaccines/immunology ; Fimbriae Proteins/antagonists & inhibitors ; Fimbriae Proteins/immunology ; Humans ; Immunoconjugates/administration & dosage ; Immunoconjugates/immunology ; Male ; Mice ; Single-Domain Antibodies/immunology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial.
Autorzy:
Talaat KR; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States of America.
Porter CK; Naval Medical Research Center, Silver Spring, MD, United States of America.
Jaep KM; Henry M. Jackson Foundation, Bethesda, MD, United States of America.
Duplessis CA; Naval Medical Research Center, Silver Spring, MD, United States of America.
Gutierrez RL; Naval Medical Research Center, Silver Spring, MD, United States of America.
Maciel M Jr; Henry M. Jackson Foundation, Bethesda, MD, United States of America.
Adjoodani B; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States of America.
Feijoo B; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States of America.
Chakraborty S; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States of America.
Brubaker J; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States of America.
Trop SA; Henry M. Jackson Foundation, Bethesda, MD, United States of America.
Riddle MS; Naval Medical Research Center, Silver Spring, MD, United States of America.; Uniformed Services University of the Health Sciences, Bethesda, MD, United States of America.
Joseph SS; Henry M. Jackson Foundation, Bethesda, MD, United States of America.
Bourgeois AL; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States of America.; PATH, Washington, DC, United States of America.
Prouty MG; Naval Medical Research Center, Silver Spring, MD, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Dec 02; Vol. 15 (12), pp. e0239888. Date of Electronic Publication: 2020 Dec 02 (Print Publication: 2020).
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Escherichia coli Vaccines*
Antigens, Bacterial/*analysis
Diarrhea/*etiology
Enterotoxigenic Escherichia coli/*pathogenicity
Escherichia coli Infections/*microbiology
Escherichia coli Proteins/*analysis
Adolescent ; Adult ; Antibodies, Bacterial/blood ; Antigens, Bacterial/immunology ; Bacterial Load ; Bacterial Toxins/immunology ; Ciprofloxacin/therapeutic use ; Diarrhea/microbiology ; Diarrhea/therapy ; Dose-Response Relationship, Immunologic ; Enterotoxigenic Escherichia coli/immunology ; Enterotoxigenic Escherichia coli/isolation & purification ; Enterotoxins/immunology ; Escherichia coli Infections/prevention & control ; Escherichia coli Proteins/immunology ; Fasting ; Feces/microbiology ; Female ; Fluid Therapy ; Humans ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Lipopolysaccharides/immunology ; Male ; Middle Aged ; Random Allocation ; Time Factors ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
In silico analysis and in vivo assessment of a novel epitope-based vaccine candidate against uropathogenic Escherichia coli.
Autorzy:
Hasanzadeh S; Department of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran.
Habibi M; Department of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran.
Shokrgozar MA; National Cell Bank, Pasteur Institute of Iran, Tehran, Iran.
Ahangari Cohan R; Department of Nanobiotechnology, Pasteur Institute of Iran, Tehran, Iran.
Ahmadi K; Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Asadi Karam MR; Department of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran. m_.
Bouzari S; Department of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Oct 01; Vol. 10 (1), pp. 16258. Date of Electronic Publication: 2020 Oct 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Escherichia coli Infections/*prevention & control
Escherichia coli Vaccines/*therapeutic use
Urinary Tract Infections/*prevention & control
Uropathogenic Escherichia coli/*immunology
Animals ; Computer Simulation ; Cytokines/metabolism ; Epitopes/immunology ; Escherichia coli Infections/immunology ; Escherichia coli Vaccines/immunology ; Immunoglobulin G/immunology ; Mice ; Mice, Inbred BALB C ; Molecular Docking Simulation ; Toll-Like Receptor 4/metabolism ; Urinary Tract Infections/immunology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Biochemical and immunological characterization of an ETEC CFA/I adhesin cholera toxin B subunit chimera.
Autorzy:
Jobling MG; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, United States of America.
Poole ST; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Rasulova-Lewis F; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
O'Dowd A; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
McVeigh AL; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Balakrishnan A; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Sincock SA; Enteric Diseases Department, Naval Medical Research Center, Silver Spring, MD, United States of America.
Prouty MG; Enteric Diseases Department, Naval Medical Research Center, Silver Spring, MD, United States of America.
Holmes RK; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, United States of America.
Savarino SJ; Enteric Diseases Department, Naval Medical Research Center, Silver Spring, MD, United States of America.; Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Mar 16; Vol. 15 (3), pp. e0230138. Date of Electronic Publication: 2020 Mar 16 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Cholera Toxin*/genetics
Cholera Toxin*/immunology
Cholera Toxin*/metabolism
Enterotoxigenic Escherichia coli*/immunology
Escherichia coli Vaccines*/immunology
Fimbriae Proteins*/genetics
Fimbriae Proteins*/immunology
Fimbriae Proteins*/metabolism
Recombinant Fusion Proteins*/immunology
Recombinant Fusion Proteins*/metabolism
Animals ; Female ; Mice ; Adhesins, Bacterial/immunology ; Adhesins, Bacterial/metabolism ; Adjuvants, Immunologic/administration & dosage ; Immunization ; Immunogenicity, Vaccine ; Mice, Inbred BALB C
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Expression fusion immunogen by live attenuated Escherichia coli against enterotoxins infection in mice.
Autorzy:
Feng N; College of Life Science and Resource Environment, Yichun University, Yichun, China.
Guan W; College of Life Science and Resource Environment, Yichun University, Yichun, China.
Pokaż więcej
Źródło:
Microbial biotechnology [Microb Biotechnol] 2019 Sep; Vol. 12 (5), pp. 946-961. Date of Electronic Publication: 2019 Jun 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigens, Bacterial/*immunology
Diarrhea/*veterinary
Enterotoxigenic Escherichia coli/*immunology
Enterotoxins/*immunology
Escherichia coli Infections/*veterinary
Escherichia coli Vaccines/*immunology
Swine Diseases/*prevention & control
Administration, Oral ; Animals ; Antibodies, Bacterial/blood ; Antigens, Bacterial/genetics ; Diarrhea/microbiology ; Diarrhea/prevention & control ; Enterotoxins/antagonists & inhibitors ; Enterotoxins/genetics ; Escherichia coli Infections/microbiology ; Escherichia coli Infections/prevention & control ; Escherichia coli Vaccines/administration & dosage ; Feces/chemistry ; Immunity, Cellular ; Immunoglobulin A, Secretory/analysis ; Immunoglobulin G/blood ; Mice, Inbred BALB C ; Recombinant Fusion Proteins/genetics ; Recombinant Fusion Proteins/immunology ; Swine ; Swine Diseases/microbiology ; Treatment Outcome ; Vaccines, Attenuated/administration & dosage ; Vaccines, Attenuated/immunology ; Vaccines, Synthetic/administration & dosage ; Vaccines, Synthetic/immunology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A novel Salmonella strain inactivated by a regulated autolysis system and expressing the B subunit of Shiga toxin 2e efficiently elicits immune responses and confers protection against virulent Stx2e-producing Escherichia coli.
Autorzy:
Won G; College of Veterinary Medicine, Chonbuk National University, Iksan campus, Gobong-ro 79, Iksan, 54596, Republic of Korea.
Kim TH; College of Veterinary Medicine, Chonbuk National University, Iksan campus, Gobong-ro 79, Iksan, 54596, Republic of Korea.
Lee JH; College of Veterinary Medicine, Chonbuk National University, Iksan campus, Gobong-ro 79, Iksan, 54596, Republic of Korea. .
Pokaż więcej
Źródło:
BMC veterinary research [BMC Vet Res] 2017 Feb 01; Vol. 13 (1), pp. 40. Date of Electronic Publication: 2017 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Escherichia coli/*immunology
Escherichia coli Infections/*prevention & control
Escherichia coli Vaccines/*immunology
Salmonella typhimurium/*immunology
Shiga Toxin 2/*immunology
Animals ; Cell Proliferation ; Cytokines/biosynthesis ; Escherichia coli Infections/immunology ; Escherichia coli Vaccines/genetics ; Female ; Immunity, Cellular ; Immunity, Humoral ; Mice ; Mice, Inbred BALB C ; Salmonella typhimurium/genetics ; Shiga Toxin 2/genetics ; Swine ; T-Lymphocytes/immunology ; Vaccines, Synthetic/immunology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Novel fusion antigen displayed-bacterial ghosts vaccine candidate against infection of Escherichia coli O157:H7.
Autorzy:
Cai K; State Key Laboratory of Pathogens and Biosecurity, Beijing Institute of Microbiology and Epidemiology, No. 20 Dongdajie, Fengtai District, Beijing 100071, PR China.
Tu W; State Key Laboratory of Pathogens and Biosecurity, Beijing Institute of Microbiology and Epidemiology, No. 20 Dongdajie, Fengtai District, Beijing 100071, PR China.
Liu Y; State Key Laboratory of Pathogens and Biosecurity, Beijing Institute of Microbiology and Epidemiology, No. 20 Dongdajie, Fengtai District, Beijing 100071, PR China.
Li T; State Key Laboratory of Pathogens and Biosecurity, Beijing Institute of Microbiology and Epidemiology, No. 20 Dongdajie, Fengtai District, Beijing 100071, PR China.
Wang H; Department of Microbiology, Anhui Medical University, Hefei, 230032, PR China.; State Key Laboratory of Pathogens and Biosecurity, Beijing Institute of Microbiology and Epidemiology, No. 20 Dongdajie, Fengtai District, Beijing 100071, PR China.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2015 Dec 02; Vol. 5, pp. 17479. Date of Electronic Publication: 2015 Dec 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigens, Bacterial/*pharmacology
Escherichia coli O157/*immunology
Escherichia coli Vaccines/*pharmacology
Hemolytic-Uremic Syndrome/*prevention & control
Shiga Toxin 1/*pharmacology
Shiga Toxin 2/*pharmacology
Animals ; Antibodies, Bacterial/immunology ; Antigens, Bacterial/genetics ; Antigens, Bacterial/immunology ; Escherichia coli O157/genetics ; Escherichia coli Vaccines/genetics ; Escherichia coli Vaccines/immunology ; Hemolytic-Uremic Syndrome/genetics ; Hemolytic-Uremic Syndrome/immunology ; Immunoglobulin A/immunology ; Immunoglobulin G/immunology ; Mice ; Mice, Inbred BALB C ; Recombinant Fusion Proteins/genetics ; Recombinant Fusion Proteins/immunology ; Recombinant Fusion Proteins/pharmacology ; Shiga Toxin 1/genetics ; Shiga Toxin 1/immunology ; Shiga Toxin 2/genetics ; Shiga Toxin 2/immunology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Construction and evaluation of a fluorescence-based live attenuated Escherichia coli delivery system for generating oral vaccine candidate.
Autorzy:
Liu W; Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Northeast Agricultural University, Harbin, Heilongjiang, 150030, People's Republic of China.
Li X
Bao J
Guan W
Zhao Z
Yuan C
Tang J
Shi D
Pokaż więcej
Źródło:
Applied microbiology and biotechnology [Appl Microbiol Biotechnol] 2015 May; Vol. 99 (9), pp. 4005-18. Date of Electronic Publication: 2015 Jan 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Fluorescence*
Genes, Reporter*
Bacterial Toxins/*immunology
Enterotoxins/*immunology
Escherichia coli/*immunology
Escherichia coli Proteins/*immunology
Escherichia coli Vaccines/*immunology
Administration, Oral ; Animals ; Antibodies, Bacterial/analysis ; Antibodies, Bacterial/blood ; Antibodies, Neutralizing/analysis ; Antibodies, Neutralizing/blood ; Bacterial Toxins/genetics ; Cell Proliferation ; Enterotoxins/genetics ; Enzyme-Linked Immunosorbent Assay ; Escherichia coli/genetics ; Escherichia coli Proteins/genetics ; Escherichia coli Vaccines/administration & dosage ; Escherichia coli Vaccines/genetics ; Feces/chemistry ; Immunoglobulin A/analysis ; Immunoglobulin A/blood ; Immunoglobulin G/analysis ; Immunoglobulin G/blood ; Mice, Inbred BALB C ; Serum/chemistry ; T-Lymphocytes/immunology ; Vaccines, Attenuated/administration & dosage ; Vaccines, Attenuated/genetics ; Vaccines, Attenuated/immunology ; Vaccines, Synthetic/administration & dosage ; Vaccines, Synthetic/genetics ; Vaccines, Synthetic/immunology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Evaluation of commercially available aroA delated gene E. coli O78 vaccine in commercial broiler chickens under Middle East simulating field conditions.
Autorzy:
Galal HM; Department of Microbiology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
Abdrabou MI; Department of Cytology and Histology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
Faraag AHI; Botany and Microbiology Department, Faculty of Science, Helwan University, Ain Helwan, Cairo, 11795, Egypt. professor_.
Mah CK; Outcomes Research Director, APAC & Greater China Clusters, Zoetis Inc., Parsippany, USA.
Tawfek AM; Department of Clinical Pathology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jan 21; Vol. 11 (1), pp. 1938. Date of Electronic Publication: 2021 Jan 21.
Typ publikacji:
Journal Article
MeSH Terms:
Escherichia coli Infections/*microbiology
Escherichia coli Vaccines/*pharmacology
Poultry Diseases/*microbiology
Vaccines, Attenuated/*pharmacology
Animals ; Chickens/microbiology ; Escherichia coli/drug effects ; Escherichia coli/pathogenicity ; Escherichia coli Infections/prevention & control ; Escherichia coli Infections/veterinary ; Poultry Diseases/prevention & control ; Serogroup
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Novel biotechnological approaches for monitoring and immunization against resistant to antibiotics Escherichia coli and other pathogenic bacteria.
Autorzy:
Belizário JE; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Av. Lineu Prestes, 1524, São Paulo, SP, CEP 05508-900, Brazil. .
Sircili MP; Laboratory of Genetics, Butantan Institute, Av. Vital Brazil, 1500, São Paulo, SP, CEP 05503-900, Brazil.
Pokaż więcej
Źródło:
BMC veterinary research [BMC Vet Res] 2020 Nov 02; Vol. 16 (1), pp. 420. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji:
Journal Article
MeSH Terms:
Biotechnology*
Drug Resistance, Bacterial*
Enterotoxigenic Escherichia coli/*immunology
Animals ; Anti-Bacterial Agents/pharmacology ; Bacteria/immunology ; Bacterial Infections/immunology ; Chickens ; Enterotoxigenic Escherichia coli/genetics ; Escherichia coli Infections/immunology ; Escherichia coli Infections/veterinary ; Escherichia coli Vaccines/immunology ; Humans ; Probiotics ; Virulence Factors/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Optimizing the Protection of Cattle against Escherichia coli O157:H7 Colonization through Immunization with Different Combinations of H7 Flagellin, Tir, Intimin-531 or EspA.
Autorzy:
McNeilly TN; Moredun Research Institute, Edinburgh, United Kingdom.
Mitchell MC; Moredun Research Institute, Edinburgh, United Kingdom.
Corbishley A; Moredun Research Institute, Edinburgh, United Kingdom; Division of Immunity and Infection, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
Nath M; Biomathematics and Statistics Scotland, Edinburgh, United Kingdom.
Simmonds H; Division of Immunity and Infection, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
McAteer SP; Division of Immunity and Infection, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
Mahajan A; Division of Immunity and Infection, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
Low JC; Division of Immunity and Infection, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
Smith DG; Moredun Research Institute, Edinburgh, United Kingdom; Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, United Kingdom.
Huntley JF; Moredun Research Institute, Edinburgh, United Kingdom.
Gally DL; Division of Immunity and Infection, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 May 28; Vol. 10 (5), pp. e0128391. Date of Electronic Publication: 2015 May 28 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunization*
Adhesins, Bacterial/*pharmacology
Escherichia coli O157/*immunology
Escherichia coli Proteins/*pharmacology
Escherichia coli Vaccines/*pharmacology
Flagellin/*pharmacology
Adhesins, Bacterial/immunology ; Animals ; Cattle ; Escherichia coli Proteins/immunology ; Escherichia coli Vaccines/immunology ; Flagellin/immunology ; Hemolytic-Uremic Syndrome/immunology ; Hemolytic-Uremic Syndrome/prevention & control ; Humans ; Receptors, Cell Surface/immunology ; Vaccines, Subunit/immunology ; Vaccines, Subunit/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A new human challenge model for testing heat-stable toxin-based vaccine candidates for enterotoxigenic Escherichia coli diarrhea - dose optimization, clinical outcomes, and CD4+ T cell responses.
Autorzy:
Sakkestad ST; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.
Steinsland H; Centre for Intervention Science in Maternal and Child Health (CISMAC), Centre for International Health, Department of Global Public Health and Primary Care, Faculty of Medicine, University of Bergen, Bergen, Norway.; Department of Biomedicine, Faculty of Medicine, University of Bergen, Bergen, Norway.
Skrede S; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.; Division for Infectious Diseases, Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Lillebø K; Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
Skutlaberg DH; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.; Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
Guttormsen AB; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.; Department of Anesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway.
Zavialov A; Joint Biotechnology Laboratory, Department of Chemistry, University of Turku, Turku, Finland.
Paavilainen S; Joint Biotechnology Laboratory, Department of Chemistry, University of Turku, Turku, Finland.
Søyland H; Division for Infectious Diseases, Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Sævik M; Division for Infectious Diseases, Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Heien AR; Division for Infectious Diseases, Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Tellevik MG; Norwegian National Advisory Unit on Tropical Infectious Diseases, Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Barry E; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, United States of America.
Langeland N; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.; Norwegian National Advisory Unit on Tropical Infectious Diseases, Department of Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway.
Sommerfelt H; Centre for Intervention Science in Maternal and Child Health (CISMAC), Centre for International Health, Department of Global Public Health and Primary Care, Faculty of Medicine, University of Bergen, Bergen, Norway.; Norwegian Institute of Public Health, Ministry of Health and Care Services, Oslo, Norway.
Hanevik K; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.; Norwegian National Advisory Unit on Tropical Infectious Diseases, Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2019 Oct 30; Vol. 13 (10), pp. e0007823. Date of Electronic Publication: 2019 Oct 30 (Print Publication: 2019).
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
CD4-Positive T-Lymphocytes/*immunology
Enterotoxigenic Escherichia coli/*immunology
Enterotoxins/*immunology
Escherichia coli Infections/*immunology
Escherichia coli Infections/*prevention & control
Escherichia coli Vaccines/*administration & dosage
Escherichia coli Vaccines/*immunology
Adult ; Antibodies, Bacterial/blood ; Bacterial Outer Membrane Proteins/immunology ; Colony Count, Microbial ; Diarrhea/microbiology ; Diarrhea/prevention & control ; Escherichia coli Proteins/immunology ; Female ; Hot Temperature ; Humans ; Immunoglobulin A/blood ; Immunoglobulin G/blood ; Male ; Metalloproteases ; Volunteers ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Generation of an attenuated strain oral vaccine candidate using a novel double selection platform in Escherichia coli.
Autorzy:
Liu W; Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Northeast Agricultural University, Harbin, 150030, Heilongjiang, People's Republic of China.
Yuan C
Bao J
Guan W
Zhao Z
Li X
Tang J
Li D
Shi D
Pokaż więcej
Źródło:
Applied microbiology and biotechnology [Appl Microbiol Biotechnol] 2015 Jan; Vol. 99 (2), pp. 855-67. Date of Electronic Publication: 2014 Oct 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunity, Mucosal*
Escherichia coli/*immunology
Escherichia coli Infections/*prevention & control
Escherichia coli Vaccines/*immunology
Administration, Oral ; Animals ; Antibodies, Bacterial/blood ; Antibodies, Bacterial/immunology ; Antibodies, Neutralizing/blood ; Antibodies, Neutralizing/immunology ; Antigens, Bacterial/immunology ; Enterotoxins/immunology ; Escherichia coli/genetics ; Escherichia coli Infections/immunology ; Escherichia coli Vaccines/administration & dosage ; Female ; Fimbriae, Bacterial/immunology ; Immunoglobulin A/immunology ; Immunoglobulin G/immunology ; Male ; Mice ; Mice, Inbred BALB C ; Recombinant Proteins/genetics ; Recombinant Proteins/immunology ; Vaccines, Attenuated/administration & dosage ; Vaccines, Attenuated/immunology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 104

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies